1 active not recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Unknown 1 |
Follow PSMA PET: new trials by email Literature Review of PSMA PET trials Research Report on PSMA PET
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PSMA PET Combined With MRI for the Detection of PCa 68Ga-PSMA-11 - PCA, Prostate Cancer | Phase 3 | Active not recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 338 | 2025-08-18 | 2026-10-20 |
| Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 Radiopharmaceutical 18F-JK-PSMA-7, Radiopharmaceutical 18F-Fluorocholine - Prostate Cancer, 18F- Fluorocholine | Phase 3 | Unknown | ITEL Telecomunicazioni Srl | 106 | 2022-12-19 | 2024-05-22 |
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2)
18F-JK-PSMA-7 (1) · fluorocholine (1) · gallium 68 PSMA-11 (1)
ITEL Telecomunicazioni Srl (1) · Telix Pharmaceuticals (Innovations) Pty Limited (1)
Australia (1) · Italy (1) · United States (1)
PMID 15840561, PMID 20800404, PMID 21350618, PMID 21844889, PMID 23559588, PMID 23797218, PMID 24072344, PMID 24207135, PMID 24920079, PMID 25203127, PMID 25411132, PMID 25447835, PMID 27363387, PMID 28518227, PMID 30027419, PMID 30174470, PMID 30389823, PMID 30448957, PMID 30507748, PMID 31324713, PMID 31516367, PMID 31836681, PMID 31836682, PMID 34895925